Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3993794014 | Canakinumab 150 mg lyophilised powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3993795010 | Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3993796011 | Canakinumab 150 mg lyophilized powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4864321000052110 | kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | Has manufactured dose form | Lyophilized powder for conventional release solution for injection (dose form) | false | Inferred relationship | Some | ||
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | Is a | Canakinumab only product in parenteral dose form | false | Inferred relationship | Some | ||
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some | ||
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | Has basis of strength substance (attribute) | Canakinumab (substance) | false | Inferred relationship | Some | 1 | |
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | Has precise active ingredient | Canakinumab (substance) | false | Inferred relationship | Some | 1 | |
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | har täljarvärde som visar styrka | 150 (qualifier value) | false | Inferred relationship | Some | 1 | |
| kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR